drugset / Trial / NCT03405090
Differential Mechanisms of Dyspnea Relief in Advanced COPD: Opiates vs. Bronchodilators
Phase 4
Completed
20 enrolled
Dr. Denis O'Donnell
Ontario Lung Association · collabQueen's University · collab
RandomizedCrossoverDouble-blindTreatment
Summary
Activity-related breathlessness (dyspnea) is the dominant symptom and persists despite optimal medical care in as many as 50% of patients with advanced chronic obstructive pulmonary disease (COPD). The objective of this project is to determine the underlying mechanisms of the activity-related breathlessness in patients with advanced COPD. To study the different pathways involved in causing breathlessness, we will compare the effects of two treatments, opiates with oxygen versus bronchodilators, which relieve breathlessness in different ways.
Timeline
- Start
- 2017-09-20
- Primary completion
- 2022-03-21
- Completion
- 2023-03-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Fentanyl | Other / unclassified | 100 ug | Inhaled |
| Comparator | Ipratropium | Small molecule | 0.5 mg | Inhaled |
| Comparator | Salbutamol | Unknown | 2.5 mg | Inhaled |